跳至主要内容
临床试验/NCT01670903
NCT01670903Unknown不适用

the Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
试验地点
1

研究概览

简要总结

Abdominal aortic aneurysm (AAA) is a common disease that develops from degeneration of the aortic wall. The natural history of AAA is gradual expansion and if left untreated may result in rupture and death. The mechanism of the development of this disease is unknown however it appears to be multifactorial and possibly related to degradation processes within the arterial wall. There is growing evidence that Angiotensin receptor blockers ( ARBS) may have an inhibitory effect on remodelling processes within the arterial wall, thus inhibiting degeneration of the vessel wall.

Study hypothesis: ARBS are associated with smaller diameters of aortas among hypertensive patients, and are associated with a lower rate of aortic expansion compared to other antihypertensive drugs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • medically treated hypertensive patients, ages 50-80

排除标准

  • pregnant women
  • patients previously treated for aortic disease
  • unable to sign informed consent, minors

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Daniel Silverberg

Senior consultant - Vascular surgery

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验